Clinical Trial Update: PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial PREMILOC aimed to prevent bronchopulmonary dysplasia in very preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED